Roche's Parkinson's drug misses main goal in mid-stage trial
-- Roche's experimental Parkinson's disease drug, prasinezumab, failed to meet its primary objective in a mid-stage trial. The Swiss pharmaceutical giant announced...
-- Roche's experimental Parkinson's disease drug, prasinezumab, failed to meet its primary objective in a mid-stage trial. The Swiss pharmaceutical giant announced...
CINCINNATI - Cintas Corporation (NASDAQ:CTAS) reported better-than-expected second quarter earnings on Thursday, as the uniform rental and facility services provider saw strong...
- Cintas (NASDAQ: CTAS) reported fourth quarter EPS of $1.09, $0.08 better than the analyst estimate of $1.01. Revenue for the quarter came in at $2.56B versus the...
-- Palantir Technologies Inc . (NASDAQ:PLTR) stock climbed 3% following a new coverage initiation by UBS and news of an extended partnership with the U.S. Army. The...
- Paychex (NASDAQ: PAYX) reported second quarter EPS of $1.14, $0.01 better than the analyst estimate of $1.13. Revenue for the quarter came in at $1.32B versus the...
-- Shares of CrowdStrike (NASDAQ:CRWD) climbed 2.8% following the announcement that the cybersecurity firm has become the first and fastest pure play SaaS...
-- Hut 8 Corp (NASDAQ:HUT), one of North America's largest Bitcoin miners, has bolstered its Bitcoin reserves by purchasing about 990 Bitcoin for an aggregate price...
(Reuters) - CarMax (NYSE:KMX) on Thursday reported its first quarterly sales increase in more than two years, in an early sign that the used car market was rebounding from months...
-- Coinbase's (NASDAQ:COIN) advanced trading platform, Coinbase Advanced, has seen a 77% increase in traders in 2024, the company told this week. The...
-- ConAgra Brands, Inc. (NYSE: CAG) reported second-quarter fiscal 2025 results that exceeded analyst expectations for both earnings and revenue but lowered its...